RNA-Seq Blog Transcriptome Research & Industry News
Five years from now multiple myeloma will have a therapeutic backbone consisting entirely of combinations of novel agents, a leading myeloma researcher predicted. The combinations will involve immunomodulatory agents, proteasome inhibitors, and monoclonal antibodies. Stem-cell transplantation will retain a role ...
Read More »In the not-to-distant future, RNA sequencing will become standard diagnostic testing at the initial evaluation of a patient with myeloma
